Pivot Health AI Briefing — Apr 17, 2026
The Pivot Health AI Briefing discusses Revolution Medicines' significant Phase 3 trial results for pancreatic cancer treatment darax, potentially leading to accelerated FDA approval. It also touches on the concerning statistic that AI chatbots are failing patients approximately…